These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 4765768)
1. [Inhibition of "cancer cell stickiness" through bencylan-hydrogen fumarate (fluditate)]. Gastpar H Fortschr Med; 1973 Nov; 91(33):1322-8. PubMed ID: 4765768 [No Abstract] [Full Text] [Related]
2. Antithrombotic and fibrinolytic effect of bencyclane. Kovács IB; Csalay L; Csákváry G Arzneimittelforschung; 1971 Oct; 21(10):1553-6. PubMed ID: 5171885 [No Abstract] [Full Text] [Related]
3. [Inhibition of thrombocyte adhesiveness in blood by Bencyclan. Experimental and clinical findings]. Martin M; Schäfer G; Martin U Med Welt; 1972 Oct; 23(44):1605-8. PubMed ID: 4563802 [No Abstract] [Full Text] [Related]
4. [Effect of bencyclan (Fludilat) on the vascularization of extremity arteries in the animal experiment]. Schmitt G; Sczuka C Verh Dtsch Ges Inn Med; 1974; 80():960-3. PubMed ID: 4454702 [No Abstract] [Full Text] [Related]
6. [Inhibition of cancer cell stickiness, a model for the testing of in vivo thrombocyte aggregation inhibitors. IV. Effect of sulfinpyrazone]. Gastpar H Fortschr Med; 1978 Sep; 96(36):1823-7. PubMed ID: 700559 [TBL] [Abstract][Full Text] [Related]
7. The inhibition of cancer cell stickiness: a model for investigation of platelet aggregation inhibitors in vivo. V. The effect of penbutolol. Gastpar H; Weissgerber PW J Med; 1981; 12(1):1-13. PubMed ID: 6943263 [No Abstract] [Full Text] [Related]
8. Inhibition of cancer cell stickiness by the blocking of platelet aggregation. Gastpar H S Afr Med J; 1974 Mar; 48(15):621-7. PubMed ID: 4823720 [No Abstract] [Full Text] [Related]
9. Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approcach to metastasis prophylaxis. Gastpar H J Med; 1977; 8(2):103-14. PubMed ID: 268396 [TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of bencyclan on the formation of thrombi rich in blood platelets]. Deinhardt J; Poliwoda H Med Welt; 1973 Apr; 24(16):653-4. PubMed ID: 4756331 [No Abstract] [Full Text] [Related]
11. Pharmacoradiographic examination of antispasmodics. Gimes B Ther Hung; 1971; 19(4):156-61. PubMed ID: 5146137 [No Abstract] [Full Text] [Related]
12. [The effect of bencyclane hydrogen fumarate (Fludilate) on the adhesion of tumor cells in vivo and in vitro]. Schumann J Fortschr Med; 1976 Sep; 94(26):1429-32. PubMed ID: 61934 [TBL] [Abstract][Full Text] [Related]
13. The inhibition of cancer cell stickiness by somatostatin. Gastpar H; Zoltobrocki M; Weissgerber PW Res Exp Med (Berl); 1983; 182(1):1-6. PubMed ID: 6134310 [TBL] [Abstract][Full Text] [Related]
14. The inhibition of cancer cell stickness by the methylxanthine derivative pentoxifylline (BL 191). Gastpar H Thromb Res; 1974 Sep; 5(3):277-89. PubMed ID: 4373868 [No Abstract] [Full Text] [Related]
15. [The effect of bencyclane on blood sugar level, diuresis and sodium excretion]. Méhes G; Varga F Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1373+. PubMed ID: 5536643 [No Abstract] [Full Text] [Related]
16. [In vitro effects of Bencyclane on coagulability, platelet aggregation and fibrinolysis in man: preliminary research]. Ponari O; Civardi E; Dettori AG Farmaco Prat; 1974 Feb; 29(2):76-82. PubMed ID: 4455526 [No Abstract] [Full Text] [Related]
17. [Data to the pharmacology of 1-benzyl-1-(3'-dimethylamino-propoxy)-cycloheptane fumarate (EGYT-201)]. Komlós E; Petöcz LE Orv Hetil; 1968 May; 109(21):Suppl:8-12. PubMed ID: 5720729 [No Abstract] [Full Text] [Related]
18. [Effect of bencyclane on normal blood pressure and on experimental hypertension]. Rigó J; Szelenyi I Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1371+. PubMed ID: 5536642 [No Abstract] [Full Text] [Related]
19. The inhibition of thrombocyte adhesion by bencyclane: experimental and clinical results. Martin M; Schäfer G; Martin U; Juraschek H; Knüll W Thromb Res; 1974 Jun; 4(6):741-52. PubMed ID: 4844058 [No Abstract] [Full Text] [Related]
20. [Pharmacologic studies on the effect of N-(3-(1-benzyl-cycloheptyl-oxy)propyl)-N,N-dimethyl-ammonium-hydrogenfumarate]. Komlos E; Petöcz LE Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1338+. PubMed ID: 5536636 [No Abstract] [Full Text] [Related] [Next] [New Search]